{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:45:15Z","timestamp":1791863115930,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Malaysia Ministry of Higher Education","doi-asserted-by":"publisher","award":["600- RMC \/FRGS 5\/3 (018\/2024)"],"award-info":[{"award-number":["600- RMC \/FRGS 5\/3 (018\/2024)"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jmgm.2026.109591","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:33:39Z","timestamp":1790922819000},"page":"109591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structure-based drug repurposing for CDK6: Molecular docking and molecular dynamics characterization of FDA-approved non-oncological compounds"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3608-8385","authenticated-orcid":false,"given":"Syarifuddin","family":"Husain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruzianisra","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khairul Bariyyah","family":"Abd Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7798-9991","authenticated-orcid":false,"given":"Suet Lin","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6577","key":"10.1016\/j.jmgm.2026.109591_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc1495","article-title":"CDK4 and CDK6 kinases: from basic science to cancer therapy","volume":"375","author":"Fassl","year":"2022","journal-title":"Science (New York, N.Y.)"},{"issue":"11","key":"10.1016\/j.jmgm.2026.109591_bib2","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1002\/ijc.33054","article-title":"The role of CDK6 in cancer","volume":"147","author":"Nebenfuehr","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.jmgm.2026.109591_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10549-023-06866-7","article-title":"A specific anti-cyclin D1 intrabody represses breast cancer cell proliferation by interrupting the cyclin D1\u2013CDK4 interaction","volume":"198","author":"Zhao","year":"2023","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.jmgm.2026.109591_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40265-020-01461-2","article-title":"Inhibiting CDK4\/6 in breast cancer with Palbociclib, ribociclib, and abemaciclib: similarities and differences","volume":"81","author":"Braal","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.jmgm.2026.109591_bib5","article-title":"Cost-Effectiveness of adjuvant abemaciclib and ribociclib in high-risk hormone receptor-positive early breast cancer: an Indian perspective","volume":"10","author":"Sra","year":"2024","journal-title":"JCO Glob. Oncol."},{"key":"10.1016\/j.jmgm.2026.109591_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","article-title":"Drug repurposing for cancer therapy","volume":"9","author":"Xia","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109591_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","article-title":"Overcoming cancer therapeutic bottleneck by drug repurposing","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"D1","key":"10.1016\/j.jmgm.2026.109591_bib8","doi-asserted-by":"crossref","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"UniProt: the Universal Protein Knowledgebase in 2025","volume":"53","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"8016","key":"10.1016\/j.jmgm.2026.109591_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jmgm.2026.109591_bib10","first-page":"177","article-title":"Structural basis for CDK6 activation by a virus-encoded cyclin","volume":"9","author":"Schulze-Gahmen","year":"2002","journal-title":"Nat. Struct. Biol."},{"issue":"10","key":"10.1016\/j.jmgm.2026.109591_bib11","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1158\/1535-7163.MCT-16-0300","article-title":"Spectrum and degree of CDK drug interactions predicts clinical performance","volume":"15","author":"Chen","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"issue":"16","key":"10.1016\/j.jmgm.2026.109591_bib12","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2026.109591_bib13","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3332\/ecancer.2018.886","article-title":"ReDO_DB: the repurposing drugs in oncology database","volume":"12","author":"Pantziarka","year":"2018","journal-title":"ecancermedicalscience"},{"issue":"11","key":"10.1016\/j.jmgm.2026.109591_bib14","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"Zinc 15 \u2013 ligand discovery for everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model."},{"issue":"8","key":"10.1016\/j.jmgm.2026.109591_bib15","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109591_bib16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109591_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202200188","article-title":"Speed vs accuracy: effect on ligand pose accuracy of varying box size and exhaustiveness in AutoDock vina","volume":"42","author":"Agarwal","year":"2023","journal-title":"Mol. Inf."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109591_bib18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1021\/ci800293n","article-title":"Validation of molecular docking programs for virtual screening against dihydropteroate synthase","volume":"49","author":"Hevener","year":"2009","journal-title":"J. Chem. Inf. Model."},{"issue":"sup2","key":"10.1016\/j.jmgm.2026.109591_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14756366.2016.1193736","article-title":"Reliability analysis and optimization of the consensus docking approach for the development of virtual screening studies","volume":"31","author":"Poli","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109591_bib20","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1038\/s41467-023-38732-x","article-title":"Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding","volume":"14","author":"Faber","year":"2023","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.jmgm.2026.109591_bib21","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109591_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.jmgm.2026.109591_bib23","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.jmgm.2026.109591_bib24","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1021\/ci990307l","article-title":"Prediction of physicochemical parameters by atomic contributions","volume":"39","author":"Wildman","year":"1999","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.jmgm.2026.109591_bib25","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"11","key":"10.1016\/j.jmgm.2026.109591_bib26","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109591_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.jmgm.2026.109591_bib28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM General Force Field (CGenFF): a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2026.109591_bib29","series-title":"The Pymol Molecular Graphics System","author":"Schr\u00f6dinger","year":"2015"},{"issue":"9","key":"10.1016\/j.jmgm.2026.109591_bib30","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an Efficient Program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theor. Comput."},{"issue":"10","key":"10.1016\/j.jmgm.2026.109591_bib31","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"issue":"11","key":"10.1016\/j.jmgm.2026.109591_bib32","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1073\/pnas.0809645106","article-title":"Crystal structure of human CDK4 in complex with a D-type cyclin","volume":"106","author":"Day","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jmgm.2026.109591_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2022.108272","article-title":"Pharmacophore modelling, docking and molecular dynamic simulation studies in the discovery of potential human renin inhibitors","volume":"116","author":"Halimi","year":"2022","journal-title":"J. Mol. Graph. Model."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109591_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41698-026-01296-2","article-title":"AI-driven virtual screening platform identifies novel NSUN2 inhibitor candidates for targeted cancer therapy: a computational drug discovery approach","volume":"10","author":"Yu","year":"2026","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.jmgm.2026.109591_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-62703-658-0_11","article-title":"Principal component analysis: a method for determining the essential dynamics of proteins","volume":"1084","author":"David","year":"2014","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"10.1016\/j.jmgm.2026.109591_bib36","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jmgm.2009.01.006","article-title":"Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case","volume":"27","author":"Papaleo","year":"2009","journal-title":"J. Mol. Graph. Model."},{"issue":"10","key":"10.1016\/j.jmgm.2026.109591_bib37","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1021\/ct900262t","article-title":"An evaluation of explicit receptor flexibility in molecular docking using molecular dynamics and torsion angle molecular dynamics","volume":"5","author":"Armen","year":"2009","journal-title":"J. Chem. Theor. Comput."},{"issue":"9","key":"10.1016\/j.jmgm.2026.109591_bib38","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"Role of molecular dynamics and related methods in drug discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.jmgm.2026.109591_bib39","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.3390\/ijms11083016","article-title":"Advances and challenges in protein-ligand docking","volume":"11","author":"Huang","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2026.109591_bib40","first-page":"1","article-title":"Molecular docking in organic, inorganic, and hybrid systems: a tutorial review","author":"Mohanty","year":"2023","journal-title":"Monatshefte Fur Chemie"},{"issue":"4","key":"10.1016\/j.jmgm.2026.109591_bib41","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1021\/acs.jcim.6b00678","article-title":"Molecular dynamics in mixed solvents reveals protein\u2013ligand interactions, improves docking, and allows accurate binding free energy predictions","volume":"57","author":"Arcon","year":"2017","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109591_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.sbi.2011.01.010","article-title":"Advances in all atom sampling methods for modeling protein\u2013ligand binding affinities","volume":"21","author":"Gallicchio","year":"2011","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109591_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/cphc.202200491","article-title":"On the uses of PCA to characterise molecular dynamics simulations of biological macromolecules: basics and tips for an effective use","volume":"24","author":"Palma","year":"2023","journal-title":"ChemPhysChem: A European Journal of Chemical Physics and Physical Chemistry"},{"issue":"1","key":"10.1016\/j.jmgm.2026.109591_bib44","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1038\/ncomms8653","article-title":"Protein conformational plasticity and complex ligand-binding kinetics explored by atomistic simulations and Markov models","volume":"6","author":"Plattner","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109591_bib45","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1038\/ncomms4724","article-title":"Protein conformational dynamics dictate the binding affinity for a ligand","volume":"5","author":"Seo","year":"2014","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.jmgm.2026.109591_bib46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.str.2009.02.010","article-title":"Binding of small-molecule ligands to proteins: \u201cwhat You See\u201d Is Not Always \u201cWhat You Get.\u201d","volume":"17","author":"Mobley","year":"2009","journal-title":"Structure (London, England : 1993)"},{"issue":"5","key":"10.1016\/j.jmgm.2026.109591_bib47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"issue":"21","key":"10.1016\/j.jmgm.2026.109591_bib48","doi-asserted-by":"crossref","first-page":"14450","DOI":"10.1039\/C7CP07623A","article-title":"Assessing the performance of MM\/PBSA and MM\/GBSA methods. 7. Entropy effects on the performance of end-point binding free energy calculation approaches","volume":"20","author":"Sun","year":"2018","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109591_bib49","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/ijms17020144","article-title":"Insights into protein\u2013ligand interactions: mechanisms, models, and methods","volume":"17","author":"Du","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jmgm.2026.109591_bib50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/cbdd.12921","article-title":"Danazol has potential to cause PKC translocation, cell cycle dysregulation, and apoptosis in breast cancer cells","volume":"89","author":"Deka","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"issue":"24","key":"10.1016\/j.jmgm.2026.109591_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262411849","article-title":"Azelastine inhibits triple-negative breast cancer cell viability via an ARF1-Dependent mechanism","volume":"26","author":"Park","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2026.109591_bib52","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.ddtec.2014.03.008","article-title":"Restricting CNS penetration of drugs to minimise adverse events: role of drug transporters","volume":"12","author":"Bagal","year":"2014","journal-title":"Drug Discov. Today: Technologies, Epigenetics \/ Transporter Assays"},{"issue":"3","key":"10.1016\/j.jmgm.2026.109591_bib53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1389557516666161013110813","article-title":"Current State and future perspectives in QSAR models to predict Blood- brain barrier penetration in central nervous System drug R&D","volume":"17","author":"Morales","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"issue":"6","key":"10.1016\/j.jmgm.2026.109591_bib54","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2500\/aap.2009.30.3296","article-title":"Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis","volume":"30","author":"Shah","year":"2009","journal-title":"Allergy Asthma Proc."},{"issue":"12","key":"10.1016\/j.jmgm.2026.109591_bib55","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1021\/acs.jctc.8b00391","article-title":"Avoiding false positive conclusions in molecular simulation: the importance of Replicas","volume":"14","author":"Knapp","year":"2018","journal-title":"J. Chem. Theor. Comput."},{"issue":"11","key":"10.1016\/j.jmgm.2026.109591_bib56","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1021\/acs.jcim.3c00599","article-title":"Guidelines for reporting molecular dynamics simulations in JCIM publications","volume":"63","author":"Soares","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"12","key":"10.1016\/j.jmgm.2026.109591_bib57","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1021\/ci3003649","article-title":"Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges","volume":"52","author":"Vanommeslaeghe","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2026.109591_bib58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4939-9608-7_2","article-title":"Force fields for small molecules","author":"Lin","year":"2019","journal-title":"Methods Mol. Biol."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326003177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326003177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:56:54Z","timestamp":1791860214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326326003177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":58,"alternative-id":["S1093326326003177"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109591","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based drug repurposing for CDK6: Molecular docking and molecular dynamics characterization of FDA-approved non-oncological compounds","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109591"}}